| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25c76b5b8293c2914fadced494084bcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bddd83b0d4337e850c8a5e184ed0ec20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff7cf422dca38d0533b29fb1bb03717d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2fab47983ccbab60c3a1373fc79457d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-80 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-82 |
| filingDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f6d8bf2338b1be6ca01ef690f5e2392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dabac578aa9615c145962ca50376fb78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56cea072d1b40a7fb32f297f9dc4f64f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73424635659d0680d108b5bec93d7eaa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd173ed1d04cd44e225c70d02a18701 |
| publicationDate |
2016-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016304584-A1 |
| titleOfInvention |
Mafb mutants and uses thereof |
| abstract |
The present invention relates to MafB mutants and uses thereof for research, screening and therapeutic purposes. In particular, the present invention relates to a MafB mutant polypeptide comprising the sequence as set forth in SEQ ID NO: 1 or 2 or a function conservative variant thereof wherein the glutaminic acid residue at position 269 has been deleted or substituted with a basic amino acid. The present invention also relates to a MafB mutant polypeptide comprising the sequence as set forth in SEQ ID NO: 1 or 2 or a function conservative variant thereof wherein the valine residue at position 277 has been deleted or substituted with a polar amino acid. |
| priorityDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |